PROCEPT BioRobotics Corporation PRCT Non-cash Lease Accretion Expense
Non-cash Lease Accretion Expense at other companies
Other financials
Where this comes from
Reported directly by PROCEPT BioRobotics Corporation in its filing.
Tagged under the XBRL concept prct:NonCashLeaseAccretionExpense.
The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about PROCEPT BioRobotics Corporation's non-cash lease accretion expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PROCEPT BioRobotics Corporation's non-cash lease accretion expense?
- PROCEPT BioRobotics Corporation (PRCT) reported non-cash lease accretion expense of $159K in Q1 2026.
- How has PROCEPT BioRobotics Corporation's non-cash lease accretion expense changed year-over-year?
- PROCEPT BioRobotics Corporation's non-cash lease accretion expense increased by 25.2% year-over-year, from $127K to $159K.
- What is the long-term trend for PROCEPT BioRobotics Corporation's non-cash lease accretion expense?
- Over 3 years (2021 to 2025), PROCEPT BioRobotics Corporation's non-cash lease accretion expense has grown at a 13.8% compound annual growth rate (CAGR), from $345K to $508K.
- What does non-cash lease accretion expense mean?
- Reflects the non-cash interest expense associated with the accretion of lease liabilities over the term of a lease agreement. This adjustment is added back to net income because it represents a periodic accounting charge rather than an actual cash outflow. It is essential for reconciling net income to cash flow from operations under current lease accounting standards.